Between nitrofurantoin and fosfomycin, which is safe to use during the first trimester of pregnancy?

Nitrofurantoin is safer than fosfomycin in the first trimester

Nitrofurantoin is the preferred choice for first trimester use based on established safety data and guideline recommendations, while fosfomycin has limited clinical evaluation in pregnancy with outcomes not yet well studied 1.

Evidence-Based Reasoning

Guideline Recommendations

The 2019 IDSA guidelines explicitly state that nitrofurantoin and β-lactam antimicrobials are preferred because of their safety in pregnant women 1. In contrast, the same guidelines note that while fosfomycin is effective for bacterial clearance, "there is limited clinical evaluation of use in pregnancy, and outcomes such as pyelonephritis and preterm labor are not yet well studied for this regimen" 1.

Safety Profile Comparison

Nitrofurantoin:

• Large population-based study of 105,492 pregnancies found no association with major malformations (adjusted OR = 0.85,95% CI 0.67-1.08) 2
• First trimester exposure showed no increased risk for total major congenital malformations or specific malformations 2
• ACOG Committee Opinion states that nitrofurantoin may continue to be used, and prescribing in the first trimester "is still considered appropriate when no other suitable alternative antibiotics are available" 3

Fosfomycin:

• FDA labeling states it "should be used during pregnancy only if clearly needed" with the caveat that "animal reproduction studies are not always predictive of human response" 4
• Recent research (2023) showed no increased risk of major congenital anomalies in 2,724 first-trimester exposures compared to nitrofurantoin (2.0% vs 2.5%; ORa = 0.80) 5
• However, this is acknowledged as "the first large comparative study" 5, and a 2020 study noted it was "the first study specifically examining the teratogenic risk" with only 152 exposed pregnancies 6

Clinical Algorithm

For first trimester UTI treatment:

1. First-line: Nitrofurantoin (4-7 days) - established safety profile with decades of use
2. Alternative: β-lactams (ampicillin or cephalexin)
3. Consider fosfomycin only when: Nitrofurantoin and β-lactams are contraindicated or organism resistance necessitates alternative therapy

Important Caveats

• Avoid nitrofurantoin at term (near delivery) due to risk of hemolytic anemia in the newborn, though this is not relevant to first trimester use
• While newer fosfomycin data is reassuring 5, 6, the evidence base remains substantially smaller than for nitrofurantoin
• The meta-analysis showing slight increased risk with nitrofurantoin in case-control studies (OR 1.22) was not replicated in cohort studies (RR 1.01), suggesting potential confounding 7
• Duration matters: Nitrofurantoin requires 4-7 days versus single-dose fosfomycin, which may affect compliance but provides more established outcomes data 1

The weight of guideline recommendations, FDA labeling, and decades of clinical experience clearly favor nitrofurantoin as the safer first-trimester option.